Journal List > Anat Cell Biol > v.46(3) > 1071730

TOOLS
Rafati, Noorafshan, and Torabi: Stereological study of the effects of morphine consumption and abstinence on the number of the neurons and oligodendrocytes in medial prefrontal cortex of rats
Original Article
Neurobiology

Anatomy & Cell Biology 2013; 46(3): 191-197.

Published online: 30 September 2013

DOI: https://doi.org/10.5115/acb.2013.46.3.191

Stereological study of the effects of morphine consumption and abstinence on the number of the neurons and oligodendrocytes in medial prefrontal cortex of rats

Ali Rafati1, 2, Ali Noorafshan1, Nihad Torabi2

1Histomorphometry and Stereology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

2Department of Physiology, Shiraz University of Medical Sciences, Shiraz, Iran.

Corresponding author: Ali Noorafshan. Histomorphometry and Stereology Research Center, Shiraz University of Medical Sciences, P.O. Box 71345-1945, Shiraz, Iran. Tel, Fax: +98-711-2304372, noora@sums.ac.ir

Received 19 February 2013       Revised 26 May 2013       Accepted 4 June 2013

Copyright © 2013. Anatomy & Cell Biology

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Quantitative studies to date on the effects of opioid consumption and abstinence on the nervous system using modern stereological methods have not received enough attention. In addition, they have yielded controversial results. The present study was conducted to investigate the effects of morphine, with or without abstinence, on the neurons and oligodendrocytes of the medial prefrontal cortex (MPFC) in rats using quantitative stereological methods. The male rats were divided into four groups: the first (saline [SAL]) and second (morphine [MOR]) groups were treated with saline and an escalating dose of morphine (5-20 mg/kg) for 30 days, respectively; the third (SAL+abstinence [ABS]) and fourth (MOR+ABS) groups were treated in the same manner as the previous groups plus they had a 30-day abstinence period. The results showed that the volume of the MPFC and its subdivisions decreased by approximately 15% in the MOR group compared with that in the SAL group (P<0.05). In addition, the volume decreased by approximately 24% in the MOR+ABS group compared with that in the SAL+ABS group (P<0.05). The number of neurons in the MOR and MOR+ABS groups decreased by approximately 44% and 35%, respectively, compared with that in their corresponding control groups. Moreover, the number of the oligodendrocytes in the MOR and MOR+ABS groups decreased by approximately 41% and 37%, respectively. No significant difference was noted in the number of cells in the MOR and MOR+ABS groups. In conclusion, morphine consumption leads to a permanent reduction in the number of neurons and oligodendrocytes, and no additional neuron and oligodendrocyte loss occurs after abstinence.

Keywords: Morphine, Cortex, Neurons, Oligodendroglia, Stereology, Rat

Introduction

Morphine is an opiate narcotic analgesic commonly prescribed to treat moderate to severe pain. As a derivative of opium, morphine can lead to psychological and physical dependence and addiction. There are many surveys that focus on the functional and biochemical changes of the nervous system after the consumption of morphine, heroin, alcohol, marijuana, and cocaine that might be lead to addiction [1-6]. However, the structural and especially the morphometrical changes have received less attention, and the results of these studies are controversial [6-11]. Zhang et al. [12] explained that the protective and destructive roles of morphine in the neuronal system (neurons and glial) are unclear. There is evidence suggesting that morphine induces apoptotic cell death in neuronal and glial cells, whereas controversial studies support a neuroprotective role for morphine [12]. Tamura et al. [13] showed the neuroprotective effects of morphine on low-temperature-induced cell death. They reported that the neuroprotective effects of morphine were antagonized by naloxone, which is a non-selective opioid receptor antagonist [13]. Meanwhile, Hu et al. [14] reported that morphine induces apoptosis of human neurons and microglia and that naloxone blocked morphine-induced apoptosis.
In addition, the reports on the effects of morphine withdrawal on the structure of the nervous system are controversial and have not received enough attention [15, 16]. The reports on the changes in the glial cells are mainly focused on the qualitative, biochemical, and physiological alterations, but not the quantitative alteration, after drug use and abstinence [17-19].
The present study has focused on the neurons and oligodendrocytes of the medial prefrontal cortex (MPFC). The MPFC plays a major role in organizing and motivating addiction-related behavior [20, 21]. Alterations in the MPFC function may actually be associated with a predisposition to addiction [20, 21]. The present study aimed to investigate the effects of chronic morphine treatment (30 days) with or without abstinence (30 days) on the number of the neurons and oligodendrocytes in the MPFC structures. Modern stereological studies rely on the geometrical and statistical analyses and provide accurate and comparable results in quantitative research including neuropathology [22].

Materials and Methods

Animals

Twenty-four male adult Sprague Dawley rats, each weighing 250-300 g at the beginning of the experiment were randomly selected from the Laboratory Animal Center of Shiraz University of Medical Sciences (Shiraz, Iran). They were divided into four groups, each including six animals (n=6) that were acceptable for stereological survey [23]. The animals were housed under controlled humidity and temperature conditions in a 12-hour light/dark cycle with free access to food and water. Experimental protocols were approved by the Animal Ethics Committee of the Shiraz University of Medical Sciences by agreement No. 89-5431 (Shiraz, Iran).

Morphine treatment and abstinence

In this experiment, each of the animals were assigned to one of the four groups: 1) the control animals were treated with saline for 30 days (SAL); 2) the second group was chronically treated with morphine for 30 days (MOR); 3) the other control group was treated with saline for 30 days followed by another 30 days of abstinence injection (SAL+ABS); and 4) the last group was chronically treated with morphine for 30 days followed by 30 days of abstinence injections (MOR+ABS). Morphine sulfate (purchased from Temad Factory, Tehran, Iran) was dissolved in sterile saline and administrated subcutaneously at a dose of 1 ml/kg once daily for 30 days with an escalating dose of morphine. Briefly, the initial dose administered was 5 mg/kg and was increased by 5 mg/kg every five days to a maximum dose of 20 mg/kg, and continued until day 30 of the treatment [24]. The control rats received an equal volume of saline.

Tissue preparation

The animals were anesthetized with ketamine (100 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.). Then, the rats were perfused transcardially. Briefly, the rat brains were fixed by cardiac perfusion with 0.9% saline followed by 200-300 ml of 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Then, the brains were rapidly removed from the skulls, placed in buffered formaldehyde, and embedded in a paraffin block. A complete series of coronal sections were obtained, according to Paxinos and Watson [25]. The thickness of the sections was 25 µm, and they were stained with cresyl violet [26, 27].

Estimation of the volume of the MPFC and its subdivisions

The brain was executively sectioned. Nine to eleven sections were sampled in each rat in a systematic, random manner, thus with a random start and equidistant. The volume of the right MPFC and its subdivisions (anterior cingulate, prelimbic, and infralimbic areas) were estimated using the Cavalieri method (Fig. 1) [22, 28-30]. The boundary of the MPFC was considered to be between the first appearance of the forceps minor of the corpus callosum (Bregma 4.20 mm) and its decussation (Bregma 2.28 mm) [20]. The border of each region was determined at a final magnification of ×16. A grid of points was superimposed on the sampled sections (Fig. 1). This test system of points was overlaid on the image of the tissue using stereology software designed at our research center (Morphometry & Stereology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran). The estimation was made using the following formulas:
V((MPFC)=A · t
A= a(p) · ΣPi
in which "V(MPFC)" is the volume of the cortex, "t" is the distance between the sampled sections and the section thickness, "ΣPi" is the total number of points hitting the sections of MPFC and its subregions, and "a(p)" is the area per point and is calculated by multiplying "ΔX" by "ΔY" (which, in this case, was 0.2 mm2). The right upper corner of each cross was considered a point (Fig. 1).

Estimation of the numerical density and the total number of neurons and oligodendrocytes

Microscopic survey was done using a videomicroscopy system made up of a microscope (E-200, Nikon, Tokyo, Japan), a video camera, a high numerical aperture lens (×60, N.A.=1.4), and a computer and a monitor. Ten to twelve microscopic fields were studied in each rat. The microscopic fields were selected in a systematic random manner, thus with a random start and then at an equal traveling distance. Briefly, a microscopic field was selected from a corner of the slide out of the MPFC. The slide was moved at equal intervals along the X- and Y-axes using a stage micrometer. This method was continued until the whole MPFC was quantified. The numerical density of the neurons and the oligodendrocytes was estimated according to the disector ("two sections") principle within the MPFC [22, 28-30]. The oligodendrocytes were identified using staining, according to Chareyron et al. [27], who explained that oligodendrocytes are smaller than astrocytes and contain round, darkly staining nuclei that are densely packed with chromatin. To estimate the total number of cells, an oil immersion lens at a magnification of ×3,500 was used. A brief description appears under Fig. 2. The numerical density of the cells was estimated using the optical disector and the following formula:
NV=∑Q-aframe·h·∑P·tTacb-16-191-e001
in which "a(frame)" was the area of the counting frame (in this case, 736 µm2), "h" is the height of the optical disector (in this case, 10 µm), "ΣQ-" is the number of the cells counted in all disectors, "ΣP" is the total number of counted frames, "T" is the microtome setting to cut the block (in this case, 25 µm), and "t" is the real thickness of the section measured in three random areas of each microscopic slide using the microcator (MT 12, Heidenhain, Germany). In each field, the first 5 µm of the section thickness was ignored to avoid unbiased counting. This has been called a "guard zone" (Fig. 2). Cell counting was done in the next 10 µm of section thickness, which is known as "the height of the disector" or "h" (Fig. 2). The cells that were completely or partly inside the counting frame or touching the upper and right borders were counted, whereas the cells that hit the lower and left borders were not counted. In other words, just the cells whose nucleoli did not appear in the beginning of the disector height and appeared at the following optical scan were counted [22, 28-30]. The cells whose nucleoli were completely or partly inside the counting frame or touching the upper and right lines were counted "ΣQ-" (Fig. 2). "Reference trap" indicates that relying on the density (and not the total amount of the parameter) might lead to false conclusions; therefore, the numerical densities were multiplied by the MPFC volume [22, 28-30] .

Statistical analysis

The data are reported as the mean and the standard deviation (SD). Statistical comparisons between the group means were conducted by a Kruskall-Wallis test and a Mann-Whitney U-test. P≤0.05 was considered significant.

Results

Volume of the MPFC

The volume of the MPFC and its subdivisions was decreased by approximately 15% in the MOR group compared to that in the SAL group (P<0.05). In addition, the volume decreased by approximately 24% in the MOR+ABS group compared to that in the SAL+ABS group (P<0.05) (Table 1).

Number of cells

The total number of neurons significantly decreased by approximately 44% in the MOR group compared with that in the SAL group (P<0.01). It significantly decreased by approximately 35% in the MOR+ABS group compared with that in the SAL+ABS group (P<0.01) (Table 1).
The total number of oligodendrocytes significantly decreased by approximately 41% in the MOR group compared with that in the SAL group (P<0.05). It decreased by approximately 37% in the MOR+ABS group compared with that in the SAL+ABS group (P<0.05) (Table 1).
No significant difference was seen in the number of the cells in the MOR and MOR+ABS groups.

Discussion

This study used stereological methods with the aim of evaluating the effects of chronic morphine consumption and abstinence on the neurons and oligodendrocytes in the MPFC of rats. A review of the literature showed that the results of the destructive or protective effects of morphine are controversial. Hodgson et al. [31] and Mao et al. [32] reported that intrathecal consumption of morphine might induce neurotoxicity in animals. In a study by Atici et al. [33], chronic administration of morphine was reported to cause apoptosis of neurons in the parietal, frontal, temporal, occipital, entorhinal, pyriform, and hippocampal regions of the brains of rats. In addition, an in vitro study showed that morphine causes increased neurotoxicity in human neuronal cultures with apolipoprotein E [34]. Some data indicate that morphine, through the activation of opioid receptors, can promote abnormal programmed cell death by increasing the expression of pro-apoptotic protein and suppressing the expression of anti-apoptotic protein [35]. Meanwhile, there are some reports of the protective effects of morphine. For example, the protective effects of morphine in hypoxia and ischemia have been reviewed by Peart et al. [36]. In addition, Rambhia et al. [37] suggested that morphine induces a neuroprotective effect mediated by nitric oxide in a human neuroblastoma cell line against intracellular oxidative stress and neuroinflammation. In addition, Zhang et al. [38] reported that a group of chemicals containing morphine structure, such as morphinans, is also neuroprotective in several inflammatory disease models. The reason for the contrasting results might be attributed to the varying morphine doses and/or different brain regions analyzed in other research. The latter results are in line with our present findings, which indicate a permanent reduction in the number of neurons even after morphine abstinence. Bekheet et al. [39] also reported that Purkinje cells of the cerebellum decreased in number after 30 days of morphine sulphate administration in albino rats. Analysis of our data showed that the volume of MPFC is affected by morphine treatment. This is in agreement with the study by Pezawas et al. [6] who found a significant cortical volume loss, including frontal lobe volume of the brain in opioid-dependent patients. In addition, our data shows neuronal loss after morphine consumption. Therefore, our study is in agreement with those studies that report the neurotoxic effects of morphine. In addition, our data shows that after withdrawal of morphine (MOR+ABS), the percent neuron loss was nearly the same as that in the MOR group. This shows that there is no additional neuronal loss during the abstinence period. Thus, it appears that our study is not in line with the studies by Emeterio et al. [15] and Spiga et al. [40]. The results of the Emeterio et al.'s study [15] suggest a neurotoxic effect exerted by chronic morphine treatment and its withdrawal. In line with the evaluation by Spiga et al. [40], our study revealed a reduction in the area and perimeter of the somata of tyrosine hydroxylase-positive neurons in the ventrotegmental area of morphine-withdrawn rats.
The other finding from the present experiment is the significant reduction in the number of oligodendrocytes in the MPFC even after 30 days of abstinence. Analysis of the data in the current study demonstrates that the oligodendrocytes were lost after morphine consumption.The withdrawal period could compensate for the cell loss, and no new regeneration of cells was noted. Simultaneous loss of neurons and oligodendrocytes was also observed. This is in accordance with the report by Zehr et al. [41] that showed that axonal degeneration in dying neurons causes oligodendrocytes to undergo apoptosis. The exact mechanisms for both the protective and destructive pathways are unclear and still under investigation [12].
The number of neurons in the MOR+ABS group appears greater than that in the MOR group. A similar result is noted in the comparison of the SAL+ABS group with the SAL group. The age of the rats appear to be responsible for this result. At the beginning of the study, the age of the MOR (or SAL) group was lower than that of the MOR+ABS (or SAL+ABS) group (approximately 70 vs. 100 days).
The current study used stereological methods to obtain unbiased quantitative data. The numerical density of the cells was converted to the total number to prevent the reference trap [42].

Conclusion

Morphine consumption induces a permanent reduction in the number of neurons as well as the oligodendrocytes, in the MPFC of rats. After abstinence, no additional neuron and oligodendrocytes loss was noted.

Figures and Tables

Fig. 1
The Cavalieri method. The volume of the medial prefrontal cortex (MPFC) and its subdivisions; anterior cingulated (Cg1), prelimbic (PrL), and infralimbic areas (IL) were estimated using Cavalieri's method. (A) The MPFC was sectioned executively. Nine to twelve sections were sampled (here 9). "t" is the distance between the sampled sections. (B) A grid of points was superimposed on the sampled sections. "a(p)" is the area per point and is calculated by multiplying "ΔX" by "ΔY". The arrow indicates the point that is the right upper corner of the cross. Cresyl-violet staining.
acb-46-191-g001
Fig. 2
Estimation of numerical density. (A) A schematic drawing of a microscopic slide with a section of the medial prefrontal cortex mounted on it. "h" is the height of the optical disector and "t" is the real thickness of the section. In each field, the first 5 µm of the section thickness was ignored (guard zone: gz), and cell counting was done in the next 10 µm of the section thickness "h". (B, C) Sampling of cells using optical disector. The unbiased counting frame was superimposed on the images. Just the cells whose nucleoli did not appear in the beginning of the disector height (B) and appeared at the following optical scan (C) were counted. The cells whose nucleoli were completely or partly inside the counting frame or touching the upper and right lines were counted as "ΣQ-". Cresyl-violet staining.
acb-46-191-g002
Table 1
Mean±SD of the total number of the neurons, oligodendrocytes, and the volume (mm3) of medial prefrontal cortex (MPFC) in 30 days morphine treated rats (MOR), without or with 30 days abstinence (ABS), and saline-treated controls (SAL) (n=6)
acb-46-191-i001

*P<0.05, (SAL vs. MOR) or (SAL+ABS vs. MOR+ABS). †P<0.01, (SAL vs. MOR) or (SAL+ABS vs. MOR+ABS).

Acknowledgements

This study is a part of Nihad Torabi's M.Sc. thesis in physiology. The work was financially supported by grant No. 89-5431 from Shiraz University of Medical Sciences. The authors would like to thank Miss. Elham Nadimi for her technical assistance. The Research Improvement Center of Shiraz University of Medical Sciences and Ms. Afsaneh Keivanshekouh are also appreciated for improving the use of English in the manuscript.

References

1. Liu LW, Lu J, Wang XH, Fu SK, Li Q, Lin FQ. Neuronal apoptosis in morphine addiction and its molecular mechanism. Int J Clin Exp Med. 2013; 6:540–545.
2. Spiga S, Puddu MC, Pisano M, Diana M. Morphine withdrawal-induced morphological changes in the nucleus accumbens. Eur J Neurosci. 2005; 22:2332–2340.
3. Fattore L, Puddu MC, Picciau S, Cappai A, Fratta W, Serra GP, Spiga S. Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy. Neuroscience. 2002; 110:1–6.
4. Ballesteros-Yáñez I, Ambrosio E, Benavides-Piccione R, Pérez J, Torres I, Miguéns M, García-Lecumberri C, DeFelipe J. The effects of morphine self-administration on cortical pyramidal cell structure in addiction-prone lewis rats. Cereb Cortex. 2007; 17:238–249.
5. Medina KL, McQueeny T, Nagel BJ, Hanson KL, Schweinsburg AD, Tapert SF. Prefrontal cortex volumes in adolescents with alcohol use disorders: unique gender effects. Alcohol Clin Exp Res. 2008; 32:386–394.
6. Pezawas LM, Fischer G, Diamant K, Schneider C, Schindler SD, Thurnher M, Ploechl W, Eder H, Kasper S. Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurements. Psychiatry Res. 1998; 83:139–147.
7. Amass L, Nardin R, Mendelson JH, Teoh SK, Woods BT. Quantitative magnetic resonance imaging in heroin- and cocaine-dependent men: a preliminary study. Psychiatry Res. 1992; 45:15–23.
8. Lyoo IK, Pollack MH, Silveri MM, Ahn KH, Diaz CI, Hwang J, Kim SJ, Yurgelun-Todd DA, Kaufman MJ, Renshaw PF. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl). 2006; 184:139–144.
9. Daglish MR, Weinstein A, Malizia AL, Wilson S, Melichar JK, Britten S, Brewer C, Lingford-Hughes A, Myles JS, Grasby P, Nutt DJ. Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. Am J Psychiatry. 2001; 158:1680–1686.
10. Rapeli P, Kivisaari R, Autti T, Kähkönen S, Puuskari V, Jokela O, Kalska H. Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry. 2006; 6:9.
11. Mann K, Agartz I, Harper C, Shoaf S, Rawlings RR, Momenan R, Hommer DW, Pfefferbaum A, Sullivan EV, Anton RF, Drobes DJ, George MS, Bares R, Machulla HJ, Mundle G, Reimold M, Heinz A. Neuroimaging in alcoholism: ethanol and brain damage. Alcohol Clin Exp Res. 2001; 25:5 Suppl ISBRA. 104S–109S.
12. Zhang Y, Chen Q, Yu LC. Morphine: a protective or destructive role in neurons? Neuroscientist. 2008; 14:561–570.
13. Tamura Y, Monden M, Shintani M, Kawai A, Shiomi H. Neuroprotective effects of hibernation-regulating substances against low-temperature-induced cell death in cultured hamster hippocampal neurons. Brain Res. 2006; 1108:107–116.
14. Hu S, Sheng WS, Lokensgard JR, Peterson PK. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology. 2002; 42:829–836.
15. Emeterio EP, Tramullas M, Hurlé MA. Modulation of apoptosis in the mouse brain after morphine treatments and morphine withdrawal. J Neurosci Res. 2006; 83:1352–1361.
16. Droblenkov AV, Karelina NR, Shabanov PD. Changes in neurons and gliocytes in the mesoaccumbocingulate system on perinatal exposure to morphine in rats. Neurosci Behav Physiol. 2010; 40:848–851.
17. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2001; 2:119–128.
18. Bonci A, Williams JT. Increased probability of GABA release during withdrawal from morphine. J Neurosci. 1997; 17:796–803.
19. Manzoni OJ, Williams JT. Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J Neurosci. 1999; 19:6629–6636.
20. Van den Oever MC, Spijker S, Smit AB, De Vries TJ. Prefrontal cortex plasticity mechanisms in drug seeking and relapse. Neurosci Biobehav Rev. 2010; 35:276–284.
21. Myers-Schulz B, Koenigs M. Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol Psychiatry. 2012; 17:132–141.
22. Kristiansen SL, Nyengaard JR. Digital stereology in neuropathology. APMIS. 2012; 120:327–340.
23. Hyde DM, Tyler NK, Plopper CG. Morphometry of the respiratory tract: avoiding the sampling, size, orientation, and reference traps. Toxicol Pathol. 2007; 35:41–48.
24. Li Q, Zhao X, Zhong LJ, Yang HY, Wang Q, Pu XP. Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia. Eur J Pharmacol. 2009; 612:21–28.
25. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 5th ed. San Diego: Elsevier Academic Press;2005.
26. Davanlou M, Smith DF. Unbiased stereological estimation of different cell types in rat cerebral cortex. Image Anal Stereol. 2004; 23:1–11.
27. Chareyron LJ, Lavenex PB, Lavenex P. Postnatal development of the amygdala: a stereological study in rats. J Comp Neurol. 2012; 520:3745–3763.
28. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sørensen FB, Vesterby A, West MJ. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 1988; 96:379–394.
29. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sørensen FB, Vesterby A, West MJ. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 1988; 96:857–881.
30. Boyce RW, Dorph-Petersen KA, Lyck L, Gundersen HJ. Design-based stereology: introduction to basic concepts and practical approaches for estimation of cell number. Toxicol Pathol. 2010; 38:1011–1025.
31. Hodgson PS, Neal JM, Pollock JE, Liu SS. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg. 1999; 88:797–809.
32. Mao J, Sung B, Ji RR, Lim G. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci. 2002; 22:7650–7661.
33. Atici S, Cinel L, Cinel I, Doruk N, Aktekin M, Akca A, Camdeviren H, Oral U. Opioid neurotoxicity: comparison of morphine and tramadol in an experimental rat model. Int J Neurosci. 2004; 114:1001–1011.
34. Turchan-Cholewo J, Liu Y, Gartner S, Reid R, Jie C, Peng X, Chen KC, Chauhan A, Haughey N, Cutler R, Mattson MP, Pardo C, Conant K, Sacktor N, McArthur JC, Hauser KF, Gairola C, Nath A. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. Neurobiol Dis. 2006; 23:109–119.
35. Boronat MA, García-Fuster MJ, García-Sevilla JA. Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. Br J Pharmacol. 2001; 134:1263–1270.
36. Peart JN, Gross ER, Gross GJ. Opioid-induced preconditioning: recent advances and future perspectives. Vascul Pharmacol. 2005; 42:211–218.
37. Rambhia S, Mantione KJ, Stefano GB, Cadet P. Morphine modulation of the ubiquitin-proteasome complex is neuroprotective. Med Sci Monit. 2005; 11:BR386–BR396.
38. Zhang W, Hong JS, Kim HC, Zhang W, Block ML. Morphinan neuroprotection: new insight into the therapy of neurodegeneration. Crit Rev Neurobiol. 2004; 16:271–302.
39. Bekheet SH, Saker SA, Abdel-Kader AM, Younis AE. Histopathological and biochemical changes of morphine sulphate administration on the cerebellum of albino rats. Tissue Cell. 2010; 42:165–175.
40. Spiga S, Serra GP, Puddu MC, Foddai M, Diana M. Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur J Neurosci. 2003; 17:605–612.
41. Zehr C, Lewis J, McGowan E, Crook J, Lin WL, Godwin K, Knight J, Dickson DW, Hutton M. Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice. Neurobiol Dis. 2004; 15:553–562.
42. Namavar MR, Raminfard S, Jahromi ZV, Azari H. Effects of high-fat diet on the numerical density and number of neuronal cells and the volume of the mouse hypothalamus: a stereological study. Anat Cell Biol. 2012; 45:178–184.
TOOLS
Similar articles